Cervical cancer is one of the most common malignancies and is diagnosed at the lowest average age of any gynecologic cancer. The standard treatment for early cervical cancer is radical hysterectomy.
high risk for intrauterine infection during pregnancy. Because many researchers describe only the course and outcome of pregnancy, and not the conditions before conception, there are few reports involving fertility treatment after a radical trachelectomy. We investigated infertility factors after abdominal trachelectomy because our facility has adopted this procedure. In addition to common infertility factors, abdominal trachelectomy patients may be predisposed to Asherman's syndrome. The purpose of this report was to clarify the infertility problems that occur in patients after an abdominal trachelectomy.
| MATERIAL AND ME THODS
We performed abdominal trachelectomy in 173 cervical cancer pa- The preoperative criteria for cervical cancer were as follows: (1) stage IB1 or less advanced squamous cell carcinoma (including stage IIA1, with <1 cm vaginal involvement) with a maximum transverse diameter of ≤3 cm and ≥1 cm of cancer-free space between the edge of the tumor and the internal os; and (2) stage IB1 or less advanced adenocarcinoma/adenosquamous carcinoma with a maximum transverse diameter ≤2 cm and mainly superficial or exophytic growth.
When the transverse and longitudinal diameters were almost at the upper limits of the eligibility criteria, neoadjuvant chemotherapy with paclitaxel and carboplatin was occasionally administered.
The exclusion criteria with respect to cancer-related factors included a histologic type of cancer indicative of a poor prognosis (eg, small cell carcinoma) and suspicion of extrauterine spread based on imaging findings. The intraoperative eligibility criteria were the absence of lymph node metastasis and a ≥5-mm cancer-free margin in the cervical canal of the extirpated cervix.
Lymph node metastasis was evaluated by serial frozen sections of the bilateral sentinel lymph nodes (SLNs), as previously reported.
Patients with positive SLN metastasis were converted to a hysterectomy. Our trachelectomy patients were negative for SLN metastasis and lymphadenectomy was omitted. To decrease the intra-and postoperative complication rates, we performed ART as well as AmRT and AST. The surgical procedures for resecting the parametrium and vagina during AmRT and AST were performed as in modified radical and simple hysterectomy, respectively. The criteria for AmRT, in which less parametrium is removed than during ART, were as follows: (1) After confirmation of non-metastatic SLNs, the cervix was resected 5-10 mm below the internal os using ultrasound tomography and was sent for frozen section evaluation. If a positive lymph node or cervical margin was diagnosed, the trachelectomy was converted to a hysterectomy. For high-risk patients (confirmed by postoperative pathologic results), adjuvant chemotherapy consisting of taxane and carboplatin was administered using a gonadotropin-releasing hormone agonist for ovarian protection. We recommend that patients postpone conception for 3 months after AST or 6 months after AmRT or ART. 4 We retrospectively reviewed the medical records of 37 post-trachelectomy patients who received infertility treatments or were evaluated for abnormal menstruation in our hospital between 2012 and 2016. We determined the clinical characteristics and complications affecting fecundity in these 37 patients. Regrettably, we do not routinely evaluate infertility factors among these patients before and after surgery. Thus, we could only examine the patients who were symptomatic. Additional characteristics of the patients are presented in Table 1 .
The serum follicle stimulating hormone (FSH) levels were determined between days 3 and 7 of the menstrual cycle in patients with menstrual bleeding. In patients with amenorrhea, we determined the serum FSH level during the follicular phase by monitoring the ovaries using transvaginal ultrasonography. In an attempt to evaluate the thickness of the endometrium, we selected the largest value of endometrial thickness in the record.
| Ethical approval
The protocol for abdominal trachelectomy was approved by the IRB of Kyushu University in March 2005. Informed consent was obtained in writing from all participants.
| RE SULTS
The majority of the 173 patients had follow-up evaluations in our hospital. We provided follow-up care to 153 patients for >3 years
Key message
Abdominal radical trachelectomy is performed to preserve fertility in patients with cervical cancer; however, little known complications, such as Asherman's syndrome, may occur which affect fecundity. to have Asherman's syndrome (11.6%). With the exception of 37 patients, the patients without symptoms did not undergo hormonal testing, and therefore the premature ovarian insufficiency (POI) rate was not available.
TA B L E 1 Characteristics of 37 patients
Of the 173 patients, 19 conceived, with a total of 25 pregnancies. Seven pregnancies were achieved spontaneously and 18 with fertility treatment. According to the record review, 85 patients had desired fertility. Therefore, the conception rate was 22%. Table 1 shows the demographic characteristics of the 37 patients who underwent both abdominal trachelectomy and subsequent treatment for infertility or evaluation of menstrual disorders at our institution. Patients 3 and 13 became pregnant following infertility treatment at our hospital. We believe that some infertility factors are directly related to a previous trachelectomy: cervical stenosis, Asherman's syndrome, and POI. Cervical stenosis has been reported to occur in 9.5%-15% of patients. Four of 37 patients showed signs of POI based on serum FSH levels >20 mIU/mL (10.8%); all of the patients had Asherman's syndrome and POI. Some of the patients recovered from amenorrhea after several months of hormone therapy. Because the patients had concomitant Asherman's syndrome, resumption of ovarian function was difficult to ascertain based on symptoms alone.
Nevertheless, the serum FSH levels tended to improve over time.
| D ISCUSS I ON
In 1994, Dargent et al 3 The reported percentage of pregnancy after trachelectomy varies widely, but rates of 55%-70% after vaginal radical trachelectomy have been reported. 5, 7, 11 Some authors indicate a lower pregnancy rate (16.2%-37.5%) after ART. 6, 12, 13 In our facility, the conception rate was 22%, which is comparatively low. Bentivegna et al 14 have also suggested that the pregnancy rate after laparotomy is significantly lower compared with other approaches. It is possible that wider resection and uterine artery resection might impair fertility in patients undergoing the abdominal approach. In a previous report, we concluded that the length of the preserved cervix is important. 4 However, once conception has been achieved, the presence or absence of uterine arteries does not affect pregnancy outcome.
We encountered four women with amenorrhea or other menstruation disorders and elevated serum FSH levels, indicating possible POI. Two of the four women with POI underwent adjuvant chemotherapy using paclitaxel and carboplatin, drugs that are not high risk for early-onset menopause. All four women had regular menstrual cycles before cancer treatment. Even taking into account that two of the women were in their late 30s, the rate of POI was high. Because there are some reports of ovarian insufficiency after uterine-artery embolization and simple hysterectomy, 15, 16 we suggest that loss of blood flow from the uterine artery may have an impact on ovarian function. Although the hormone levels of these patients assumed a postmenopausal pattern, ovarian function resumed after several months or years. This phenomenon is often noted after chemotherapy, thus if the damage to the oocyte is partial, ovarian function recovers at least transiently.
As far as can be determined from previously published studies, Asherman's syndrome is not common after trachelectomy, although
Asherman's syndrome has been diagnosed after ART. 17 Other authors have described amenorrhea after ART. 6, 18 We assume that the basis of amenorrhea may be Asherman's syndrome. Fourteen of 37 (38%) infertility or menstrual disorder patients experienced some form of Asherman's syndrome after trachelectomy, a frequency that was high compared with previous reports. Loss of blood flow from the uterine artery might have had an adverse effect on the endometrium, inducing Asherman's syndrome. There are some reports of Asherman's syndrome after uterine-artery embolization 19 and uterine devascularization for postpartum hemorrhage. 20 Based on these findings, it could be inferred that blood-flow insufficiency causes Asherman's syndrome.
There are reports of Asherman's syndrome occurring after the use of compression sutures for postpartum hemorrhage. 21, 22 Unlike vaginal radical trachelectomy, surgeons need to manipulate the uterine body during abdominal trachelectomy. The resulting pressure on the uterine body might have an adverse effect on the endometrium.
Furthermore, Asherman's syndrome tends to occur during the postpartum period; thus, decreased estrogen levels might play a role. 23 We usually use a gonadotropin-releasing hormone agonist with chemotherapy to preserve ovarian function. Such treatment lowers serum estrogen levels and may promote the development of Asherman's syndrome.
This report was limited because we investigated only 37 of 173 post-trachelectomy patients, although we assume the existence of some little known complications which affect fecundity.
We failed to restore a normal uterine cavity by repeated simple adhesiolysis. A novel technique to regenerate the endometrium is needed.
| CON CLUS ION
Radical trachelectomy might be effective for young cervical cancer patients who desire future childbearing; however, this treatment is not without its problems, as some patients experience fertility-compromising complications, such as Asherman's syndrome and POI after abdominal trachelectomy. We do not know the precise reason for these disorders, and it is difficult to treat these complications. Because spontaneous conception is uncommon in patients after abdominal trachelectomy, early fertility treatment is recommended. To prevent Asherman's syndrome and POI, surgeons should take care to handle the uterine body gently and to preserve blood flow from the ovarian arteries. Clinicians providing fertility treatment to patients who have undergone abdominal trachelectomy must note the status of the endometrial cavity. Abdominal trachelectomy might be inferior to the vaginal approach for fertility preservation. Further investigations on F I G U R E 3 Patient 17: transvaginal ultrasonography. An intrauterine device is causing an artifact; the endometrium is not identifiable F I G U R E 2 Patient 11: She was amenorrheic after trachelectomy. HSG revealed an extremely confined uterine cavity in the shape of the intrauterine device, which was inserted for prevention of cervical stenosis at the time of surgery. HSG was performed immediately after removal of the intrauterine device F I G U R E 1 Patient 9: HSG. The uterine cavity is deformed and cylindrical. The right fallopian tube is patent; the left fallopian tube appears obstructed. As sharp adhesiolysis proved difficult, we attempted blunt adhesiolysis. Postoperative HSG showed that the uterine cavity was minimally expanded, but was abnormal surgical procedures for ART are needed to achieve better fertility-sparing outcomes.
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